Clinical and Social Aspects of Psoriatic Arthritis in Pediatrics
https://doi.org/10.15690/vsp.v20i5.2318
Abstract
Psoriatic arthritis is pending issue in modern pediatric dermatology. This review highlights issues of epidemiology, clinical signs, classification, diagnosis, management of comorbid conditions of psoriatic arthritis, as well as social aspects of the disease.
Supporting agencies: Not specified.
About the Authors
Andrey L. Bakulev
Saratov State Medical University n.a. V.I. Razumovsky
Russian Federation
Disclosure of interest:
Russian Federation
Saratov.
Disclosure of interest:
Andrey L. Bakulev — conducting clinical studies with such companies as MSD, Janssen, AbbVie, LEO Pharma, UCB, BIOCAD, Dr. Reddy's Laboratories Ltd., Novartis, AMGen, Galderma, Veropharm, Pfizer, UCB. Scientific assessment of data for Eli Lilly, Janssen, AbbVie, LEO Pharma, UCB, BIOCAD, Novartis, AMGen, Galderma, Zeldis Pharma. Lecturing for Eli Lilly, Bayer, MSD, Janssen, AbbVie, LEO Pharma, UCB, BIOCAD, Dr. Reddy's Laboratories Ltd., Novartis, Galderma, Veropharm, Pfizer, Jadran (JGL), Zeldis Pharma.
Ekaterina E. Talnikova
Saratov State Medical University n.a. V.I. Razumovsky
Russian Federation
Disclosure of interest:
Russian Federation
Saratov.
Disclosure of interest:
Ekaterina E. Talnikova confirmed the absence of a reportable conflict of interests.
References
1. Murashkin NN, Materikin AI, Ambarchian ET, Epishev RV, Opryatin LA, Ivanov RA, Kukoleva DS, Kuptsova DG, Pomazanova MU. Psoriasis and Psoriatic Arthritis in Childhood Psoriasis and Psoriatic Arthritis in Childhood. Current Pediatrics. 2020;19(6):444-451. (In Russ). doi: 10.15690/vsp.v19i6.2146
2. Osier E, Wang AS, Tollefson MM, et al. Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA Dermatol. 2017;153(7):698-704. doi: 10.1001/jamadermatol.2017.0499
3. Menter A, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82(1):161-201. doi: 10.1016/j.jaad.2019.08.049
4. Stoll ML, Mellin ED. Psoriatic arthritis in childhood: A commentary on the controversy. Clinical Immunology. 2020;214:2-7. doi: 10.1016/j.clim.2020.108396
5. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55-78. doi: 10.1016/0049-0172(73)90035-8
6. Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol. 2011;23(5):437-443. doi: 10.1097/bor.0b013e328348b278
7. Meneghetti TC, et al. The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis. Advances in Rheumatology. 2020;60:33. doi: 10.1186/s42358-020-00136-6
8. Murashkin NN, Kruglova LS, Kovalenko IA, Ambarchian ET, Epishev RV, Materikin AI, Opryatin LA, Ivanov RA, Kukoleva DS, Kuptsova DG, Pomazanova MYu, Kozyr YV. Psoriasis Comorbidities in Childhood. Current Pediatrics. 2020;19(6):460-467. (In Russ). doi: 10.15690/vsp.v19i6.2149
9. Brandon TG, Manos CK, Xiao R, Ogdie A, Weiss PF. Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities. J Psoriasis Psoriatic Arthritis. 2018;3(4):131-136. doi: 10.1177/2475530318799072
10. Butbul A, et al. Juvenile Psoriatic Arthritis (JPsA): Juvenile arthritis with psoriasis? Pediatric Rheumatology. 2013;11(1):11. doi: 10.1186/1546-0096-11-11
11. Taylor W, et al. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis & Rheumatology. 2006;54(8):2665-2673. doi: 10.1002/art.21972
12. Zisman D, et al. The juvenile psoriatic arthritis cohort in the CARRA registry: Clinical characteristics, classification, and outcomes. J Rheumatol. 2017;44(3):342-351. doi: 10.3899/jrheum.160717
13. Saurenmann RK, Rose JB, Tyrrell P, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56:1974-1984. doi: 10.1002/art.22709
14. Guillaume S, Prieur AM, Coste J, Job-Deslandre C. Longterm outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum. 2000;43:1858-1865. doi: 10.1002/1529-0131(200008)43:8<1858::AID-ANR23>3.0.CO;2-A
15. Hofer MF, Mouy R, Prieur AM. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol. 2001;28:1083-1090.
16. Minden K, Niewerth M, Listing J, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2392-2401. doi: 10.1002/art.10444
17. Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: Epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64: ii14-17. doi: 10.1136/ard.2004.032482
18. Rosen CF, Mussani F, Chandran V, et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology. 2011;51:571-576. doi: 10.1093/rheumatology/ker365
19. Orbai AM, de Wit M, Mease P, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76:673-680. doi: 10.1136/annrheumdis-2016-210242
20. Ogdie A, et al. Patient's experience of psoriatic arthritis: A conceptual model based on qualitative interviews. RMD Open. 2020;6:e001321. doi: 10.1136/rmdopen-2020-001321
21. Bakulev AL, Talnikova EE. Psoriasis in Pediatrics. Current Pediatrics. 2020;19(6):496-499. (In Russ). doi: 10.15690/vsp.v19i6.2150
22. Varni JW, Globe DR, Gandra SR, et al. Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: Comparisons to four common chronic diseases. Eur J Pediatr. 2012;171(3):485-492. doi: 10.1007/s00431-011-1587-2
23. Tollefson MM, Megha M, Schoch JJ, Eton DT. Impact of childhood psoriasis on parents of affected children. J Am Acad Dermatol. 2017;76(2):286-289.e5. doi: 10.1016/j.jaad.2016.09.014
24. Edens C, Antonelli M. The Prevalence of Comorbidities in Children and Young Adults with Psoriasis and Psoriatic Arthritis. Journal of Psoriasis and Psoriatic Arthritis. 2019;4(1):22-27. doi: 10.1177/2475530318807695
25. Coates LC, Kavanaugh A, Ritchlin CT. Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA. J Rheumatol. 2014;41(11):2273-2276. doi: 10.3899/jrheum.140875
26. Okazanie meditsinskoj pomoshchi detyam s psoriazom. Baranov AA, Namazova-Baranova LS, Murashkin NN, eds. Moscow: Pediatr; 2016. 64 p. (In Russ).
27. Psoriaz u detei: klinicheskie rekomendatsii. Moscow: Soyuz pediatrov Rossii; 2016. (In Russ).
28. Napolitano M, Megna M, Balato A, Ayala F, Lembo S, Villani A, Balato N. Systemic Treatment of Pediatric Psoriasis: A Review. Dermatol Ther (Heidelb). 2016;6(2):125-142.
29. Namazova-Baranova LS, Murashkin NN, Ambarchian ET, Materikin AI. System therapy of psoriasis in children (part I). Vestnik Dermatologii i Venerologii. 2017;(4):74-81. (In Russ).
30. Baranov AA, Namazova-Baranova LS, Murashkin NN et al. Federal Clinical Guidelines of Care for the Management for Children with Psoriasis. Moscow; 2016. P. 5-10. (In Russ).
31. Paller AS, Siegfried EC, Langley RG, et al. Long-Term Safety and Efficacy of Etanercept in Children and Adolescents with Plaque Psoriasis. J. Am. Acad. Dermatol. 2016;74(2):280-287. doi: 10.1016/j.jaad.2015.09.056
32. Namazova-Baranova LS, Murashkin NN, Ambarchian ET, Materikin AI. Systemic Psoriasis Treatment at an Early Age (part II): Issues of Biological Therapy. Vestnik Dermatologii i Venerologii. 2017;(6):100-107. (In Russ). doi: 10.25208/0042-4609-2017-93-6-100-107
Review
For citations:
Bakulev A.L., Talnikova E.E. Clinical and Social Aspects of Psoriatic Arthritis in Pediatrics. Current Pediatrics. 2021;20(5):426-429. (In Russ.) https://doi.org/10.15690/vsp.v20i5.2318
Views:
442
Email this article 
